CONCLUSION: Data showed that administering Acetyl l-​-Carnitine may reduce both physical and mental fatigue in elderly and improves both the cognitive status and physical functions. 

CONCLUSION: This study demonstrates that cognitive and cerebral blood flow improvements are possible in this group with multiple interventions.

CONCLUSION: Acetyl-L-carnitine (ALC) can be recommended in the abovementioned doses for treatment of early stages of Alzheimer’s disease and Vascular Dementia.

CONCLUSION: These results suggest that feeding ALCAR and LA to old rats improves performance on memory tasks by lowering oxidative damage and improving mitochondrial function.

CONCLUSION: A recent meta-​-analysis of 21 double-​-blind clinical trials of acetyl carnitine in the treatment of mild cognitive impairment and mild Alzheimer's disease showed significant efficacy vs. placebo. A meta-​-analysis of 4 clinical trials of...

Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression. CONCLUSION: “This investigation establishes that LAC is effective in counteracting symptoms of depression in the elderly. Relief of depressive symptomatology is expressed by...